Maruo Calcium Past Earnings Performance
Past criteria checks 4/6
Maruo Calcium's earnings have been declining at an average annual rate of -6.4%, while the Chemicals industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 1.1% per year. Maruo Calcium's return on equity is 2.2%, and it has net margins of 1.9%.
Key information
-6.4%
Earnings growth rate
-6.3%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 1.1% |
| Return on equity | 2.2% |
| Net Margin | 1.9% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses Breakdown
How Maruo Calcium makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 12,889 | 249 | 1,782 | 319 |
| 31 Dec 23 | 12,819 | 270 | 1,807 | 284 |
| 30 Sep 23 | 12,719 | 191 | 1,844 | 284 |
| 30 Jun 23 | 12,493 | 186 | 1,884 | 284 |
| 31 Mar 23 | 12,594 | 117 | 1,954 | 284 |
| 31 Dec 22 | 12,538 | 136 | 1,889 | 323 |
| 30 Sep 22 | 12,152 | 150 | 1,848 | 323 |
| 30 Jun 22 | 12,021 | 176 | 1,761 | 323 |
| 31 Mar 22 | 11,567 | 190 | 1,646 | 323 |
| 31 Dec 21 | 11,437 | 258 | 1,658 | 272 |
| 30 Sep 21 | 11,317 | 278 | 1,604 | 272 |
| 30 Jun 21 | 11,094 | 202 | 1,545 | 272 |
| 31 Mar 21 | 10,844 | 179 | 1,498 | 272 |
| 31 Dec 20 | 10,754 | 10 | 1,457 | 297 |
| 30 Sep 20 | 10,929 | -27 | 1,513 | 297 |
| 30 Jun 20 | 11,348 | 27 | 1,611 | 297 |
| 31 Mar 20 | 11,869 | 117 | 1,660 | 297 |
| 31 Dec 19 | 12,202 | 239 | 1,751 | 264 |
| 30 Sep 19 | 12,560 | 336 | 1,725 | 264 |
| 30 Jun 19 | 12,797 | 402 | 1,688 | 264 |
| 31 Mar 19 | 12,771 | 404 | 1,676 | 264 |
| 31 Dec 18 | 12,747 | 402 | 1,638 | 326 |
| 30 Sep 18 | 12,516 | 403 | 1,614 | 326 |
| 30 Jun 18 | 12,173 | 405 | 1,606 | 326 |
| 31 Mar 18 | 12,036 | 383 | 1,592 | 326 |
| 31 Dec 17 | 11,974 | 377 | 1,633 | 311 |
| 30 Sep 17 | 11,907 | 459 | 1,612 | 311 |
| 30 Jun 17 | 11,866 | 450 | 1,595 | 311 |
| 31 Mar 17 | 11,807 | 497 | 1,584 | 311 |
| 31 Dec 16 | 11,864 | 499 | 1,507 | 299 |
| 30 Sep 16 | 11,960 | 439 | 1,490 | 299 |
| 30 Jun 16 | 12,046 | 393 | 1,486 | 299 |
| 31 Mar 16 | 12,056 | 309 | 1,487 | 299 |
| 31 Dec 15 | 11,950 | 380 | 1,495 | 313 |
| 30 Sep 15 | 11,757 | 323 | 1,519 | 313 |
| 30 Jun 15 | 11,468 | 273 | 1,517 | 313 |
| 31 Mar 15 | 11,396 | 328 | 1,528 | 313 |
| 31 Dec 14 | 11,290 | 295 | 1,521 | 319 |
| 30 Sep 14 | 11,157 | 339 | 1,515 | 319 |
| 30 Jun 14 | 11,038 | 364 | 1,518 | 319 |
| 31 Mar 14 | 10,760 | 387 | 1,487 | 319 |
| 31 Dec 13 | 10,212 | 361 | 1,449 | 323 |
| 30 Sep 13 | 9,820 | 333 | 1,414 | 323 |
Quality Earnings: 4102 has high quality earnings.
Growing Profit Margin: 4102's current net profit margins (1.9%) are higher than last year (0.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4102's earnings have declined by 6.4% per year over the past 5 years.
Accelerating Growth: 4102's earnings growth over the past year (112.8%) exceeds its 5-year average (-6.4% per year).
Earnings vs Industry: 4102 earnings growth over the past year (112.8%) exceeded the Chemicals industry 9.7%.
Return on Equity
High ROE: 4102's Return on Equity (2.2%) is considered low.